Evidence map›Paper›PMID 33483749›Full record

ArticleCardiovascular research2021

Inducibility, but not stability, of atrial fibrillation is increased by NOX2 overexpression in mice.

Alexandra S Mighiu, Alice Recalde, Klemen Ziberna, Ricardo Carnicer, Jakub Tomek, Gil Bub, Alison C Brewer, Sander Verheule, Ajay M Shah, Jillian N Simon and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Cardiovascular research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Oxidative stress and atrial fibrillation.Journal of molecular and cellular cardiology · 2024
    Review
  9. Review
  10. Modulation of NOX2 causes obesity-mediated atrial fibrillation.The Journal of clinical investigation · 2024
    Article
  11. Article
  12. Review
  13. Administration of USP7 inhibitor p22077 alleviates Angiotensin II (Ang II)-induced atrial fibrillation in Mice.Hypertension research : official journal of the Japanese Society of Hypertension · 2024
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Alexandra S MighiuDivision of Cardiovascular Medicine, University of Oxford, L6, West Wing, Oxford OX3 9DU, UK.ORCID 0000-0002-7714-0234
Alice RecaldeDivision of Cardiovascular Medicine, University of Oxford, L6, West Wing, Oxford OX3 9DU, UK.ORCID 0000-0001-7802-0800
Klemen ZibernaDivision of Cardiovascular Medicine, University of Oxford, L6, West Wing, Oxford OX3 9DU, UK.ORCID 0000-0003-3819-3779
Ricardo CarnicerDivision of Cardiovascular Medicine, University of Oxford, L6, West Wing, Oxford OX3 9DU, UK.ORCID 0000-0002-7440-2964
Jakub TomekDepartment of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK.ORCID 0000-0002-0157-4386
Gil BubDepartment of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK.ORCID 0000-0002-5304-0036
Alison C BrewerSchool of Cardiovascular Medicine & Sciences, King's College London, British Heart Foundation Centre of Excellence, London, UK.ORCID 0000-0002-1021-9888
Sander VerheuleDepartment of Physiology, Maastricht University, Maastricht, The Netherlands.ORCID 0000-0001-5196-5425
Ajay M ShahSchool of Cardiovascular Medicine & Sciences, King's College London, British Heart Foundation Centre of Excellence, London, UK.ORCID 0000-0002-6547-0631
Jillian N SimonDivision of Cardiovascular Medicine, University of Oxford, L6, West Wing, Oxford OX3 9DU, UK.ORCID 0000-0001-8140-7782
Barbara CasadeiDivision of Cardiovascular Medicine, University of Oxford, L6, West Wing, Oxford OX3 9DU, UK.ORCID 0000-0002-6801-1617
University of Oxford · GBKing's College London · GBMaastricht University · NL

Funding

British Heart Foundation CH/12/3/29609British Heart Foundation CH/1999001/11735British Heart Foundation FS/15/15/31364British Heart Foundation PG/18/76/34098British Heart Foundation RG/11/15/29375British Heart Foundation RG/13/11/30384British Heart Foundation RG/16/12/32451Fondation Leducq Network of Excellence 08CVD01Radcliffe Department of MedicineScholars Programme Studentship and the Clarendon Fund
6 · The paper itself

Abstract

aimsGp91-containing NADPH oxidases (NOX2) are a significant source of myocardial superoxide production. An increase in NOX2 activity accompanies atrial fibrillation (AF) induction and electrical remodelling in animal models and predicts incident AF in humans; however, a direct causal role for NOX2 in AF has not been demonstrated. Accordingly, we investigated whether myocardial NOX2 overexpression in mice (NOX2-Tg) is sufficient to generate a favourable substrate for AF and further assessed the effects of atorvastatin, an inhibitor of NOX2, on atrial superoxide production and AF susceptibility. METHODS AND

resultsNOX2-Tg mice showed a 2- to 2.5-fold higher atrial protein content of NOX2 compared with wild-type (WT) controls, which was associated with a significant (twofold) increase in NADPH-stimulated superoxide production (2-hydroxyethidium by HPLC) in left and right atrial tissue homogenates (P = 0.004 and P = 0.019, respectively). AF susceptibility assessed in vivo by transoesophageal atrial burst stimulation was modestly increased in NOX2-Tg compared with WT (probability of AF induction: 88% vs. 69%, respectively; P = 0.037), in the absence of significant alterations in AF duration, surface ECG parameters, and LV mass or function. Mechanistic studies did not support a role for NOX2 in promoting electrical or structural remodelling, as high-resolution optical mapping of atrial tissues showed no differences in action potential duration and conduction velocity between genotypes. In addition, we did not observe any genotype difference in markers of fibrosis and inflammation, including atrial collagen content and Col1a1, Il-1β, Il-6, and Mcp-1 mRNA. Similarly, NOX2 overexpression did not have consistent effects on RyR2 Ca2+ leak nor did it affect PKA or CaMKII-mediated RyR2 phosphorylation. Finally, treatment with atorvastatin significantly inhibited atrial superoxide production in NOX2-Tg but had no effect on AF induction in either genotype.

conclusionTogether, these data indicate that while atrial NOX2 overexpression may contribute to atrial arrhythmogenesis, NOX2-derived superoxide production does not affect the electrical and structural properties of the atrial myocardium.

Indexed as

Heart RateAction PotentialsAnimalsAnti-Arrhythmia AgentsAtorvastatinAtrial FibrillationDisease Models, AnimalEnzyme InductionEnzyme InhibitorsHeart AtriaMice, TransgenicMyocytes, CardiacNADPH Oxidase 2Signal TransductionSuperoxidesTime FactorsAnti-Arrhythmia AgentsAtorvastatinCYBB protein, humanEnzyme InhibitorsNADPH Oxidase 2SuperoxidesArrhythmia (mechanisms)AtorvastatinAtrial fibrillationNADPH oxidasesOxidant stress

Identifiers

PMID33483749
PMCPMC8479801
OpenAlexW3126104474

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.